A few recent examples of the FDA’s approach to drugs show how bad the agency’s risk aversion has become. The FDA has ...

This week in Pedersen's POV, our senior editor argues against FDA's huge shift in digital health — made without public ...

When Vinay Prasad was tapped to lead the Food and Drug Administration’s Center for Biologics Evaluation and Research, the health care world braced for its effect. Known for his critical analyses of ...

Commentary: Why FDA’s software precertification program may be bad for business Epstein Becker & Green's Bradley Merrill Thompson says the FDA's much-touted program is riddled with unseen costs and ...

Millions of patients across the country have urged the Food and Drug Administration (FDA) to be more proactive in approving life-saving medications. But, to some pundits, the FDA is actually being too ...

With only a handful of state legislatures still in regular session and more than a dozen in special sessions, adult vapers and users of other alternatives to combustible cigarettes are enjoying a ...

Commentary: FDA’s website has wrong information about the scope of its software regulation — and that's a big problem Ironically, the agency that goes after companies for false and misleading claims ...

The Florida Retail Federation recently sounded the alarm on the difficulties small business owners have in combatting the millions of illegal disposable Chinese vapes on the market. As the President ...

Thanks in part to the U.S. Food and Drug Administration (FDA), Americans do not have access to all sunscreens The United States is in the full throes of summer. After a rainy spring, summer arrived in ...